• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何预防和治疗药物性低血糖症。

How to prevent and treat pharmacological hypoglycemias.

作者信息

Reyes García R, Mezquita Raya P

机构信息

Unidad de Endocrinología, Hospital General Universitario Rafael Méndez, Lorca, Murcia, España; Servicio de Endocrinología, Clínica San Pedro, Almería, España.

Unidad de Endocrinología, Nutrición y Riesgo Vascular, Complejo Hospitalario Torrecárdenas, Almería, España; Servicio de Endocrinología, Clínica San Pedro, Almería, España.

出版信息

Rev Clin Esp (Barc). 2014 May;214(4):202-8. doi: 10.1016/j.rce.2013.12.011. Epub 2014 Jan 24.

DOI:10.1016/j.rce.2013.12.011
PMID:24468002
Abstract

A 58 year-old woman with type 2 diabetes diagnosed 3 years before came to our clinic. Her treatment was metformin 850 mg every 12 hours and glimepiride 4 mg every 24 hours. After the initiation of glimepiride 9 months before her weight has increased 5 kg, and she suffers frequent hypoglycemias which have affected her while driving. Her BMI is 35.5 kg/m². She has a normal eye fund exam. She has hypertension treated with telmisartán and hidroclorotiazide with adequate control, and also hypercholesterolemia treated with atorvastatine 40 mg every 24 hours. Her blood test shows an HbA1c of 7.0%, normal values of microalbuminuria, total cholesterol 149 mg/dl, HDL cholesterol 52 mg/dl, LDL cholesterol 98 mg/dl and triglycerides 123 mg/dl. Her blood pressure is 129/81 mmHg, there was no orthostatic hypotension, and her peripheral neurological examination shows normal results. In summary, our case is a young woman with type 2 diabetes and obesity, without chronic complications and which has frequent hypoglycaemia. How must this woman be evaluated and treated?

摘要

一名58岁女性,3年前被诊断为2型糖尿病,前来我院就诊。她的治疗方案是每12小时服用850毫克二甲双胍,每24小时服用4毫克格列美脲。在9个月前开始服用格列美脲后,她的体重增加了5公斤,并且频繁发生低血糖,这在她开车时对她造成了影响。她的体重指数(BMI)为35.5千克/平方米。她的眼底检查正常。她患有高血压,服用替米沙坦和氢氯噻嗪治疗,血压控制良好,还患有高胆固醇血症,每24小时服用40毫克阿托伐他汀治疗。她的血液检查显示糖化血红蛋白(HbA1c)为7.0%,微量白蛋白尿值正常,总胆固醇149毫克/分升,高密度脂蛋白胆固醇52毫克/分升,低密度脂蛋白胆固醇98毫克/分升,甘油三酯123毫克/分升。她的血压为129/81毫米汞柱,没有直立性低血压,并且她的周围神经检查结果正常。总之,我们的病例是一名患有2型糖尿病和肥胖症的年轻女性,没有慢性并发症,但频繁发生低血糖。该如何对这名女性进行评估和治疗?

相似文献

1
How to prevent and treat pharmacological hypoglycemias.如何预防和治疗药物性低血糖症。
Rev Clin Esp (Barc). 2014 May;214(4):202-8. doi: 10.1016/j.rce.2013.12.011. Epub 2014 Jan 24.
2
Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.接受利拉鲁肽或格列美脲治疗的 2 型糖尿病患者的患者报告结局,两者均作为二甲双胍的附加治疗。
Prim Care Diabetes. 2010 Jul;4(2):113-7. doi: 10.1016/j.pcd.2010.04.001. Epub 2010 May 4.
3
Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.维格列汀与格列美脲对2型糖尿病患者餐后血脂异常及胰岛素抵抗的影响比较。
Metabolism. 2014 Jul;63(7):957-67. doi: 10.1016/j.metabol.2014.04.008. Epub 2014 Apr 23.
4
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.二肽基肽酶-4抑制剂西他列汀在仅使用格列美脲或使用格列美脲与二甲双胍血糖控制不佳的2型糖尿病患者中的疗效和安全性。
Diabetes Obes Metab. 2007 Sep;9(5):733-45. doi: 10.1111/j.1463-1326.2007.00744.x. Epub 2007 Jun 26.
5
Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.格列美脲/二甲双胍联合治疗与格列本脲/二甲双胍治疗控制不佳的 2 型糖尿病患者的疗效。
J Diabetes Complications. 2009 Nov-Dec;23(6):376-9. doi: 10.1016/j.jdiacomp.2008.09.002. Epub 2008 Oct 11.
6
Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.每日一次的地特胰岛素对2型糖尿病患者口服抗糖尿病药物(OAD)使用的影响。
J Clin Pharm Ther. 2014 Apr;39(2):136-43. doi: 10.1111/jcpt.12116. Epub 2013 Dec 13.
7
Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.法国接受二甲双胍和磺脲类药物联合治疗的2型糖尿病患者的低血糖症
Diabetes Obes Metab. 2008 Jun;10 Suppl 1:16-24. doi: 10.1111/j.1463-1326.2008.00883.x.
8
Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.与 2 型糖尿病患者的梨果仙人掌、格列吡嗪和二甲双胍相关的低血糖不良药物反应。
Ann Pharmacother. 2010 Jul-Aug;44(7-8):1334-7. doi: 10.1345/aph.1P148. Epub 2010 Jun 1.
9
Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.格列美脲与吡格列酮联合治疗对二甲双胍单药治疗控制不佳的2型糖尿病患者的疗效:一项随机临床试验的结果
Curr Med Res Opin. 2006 Apr;22(4):751-9. doi: 10.1185/030079906X104786.
10
Clinical evaluation of combined therapy for type 2 diabetes.2 型糖尿病联合治疗的临床评估。
Curr Med Res Opin. 2010 May;26(5):1171-83. doi: 10.1185/03007991003733239.

引用本文的文献

1
Chronic Microvascular Complications in Sulfonylureas-Treated Diabetic Patients: Correlations with Glycemic Control, Risk Factors and Duration of the Disease.磺脲类药物治疗的糖尿病患者的慢性微血管并发症:与血糖控制、危险因素及病程的相关性
Clin Pract. 2024 Dec 30;15(1):7. doi: 10.3390/clinpract15010007.
2
Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study.利拉鲁肽在西班牙真实世界环境中的临床疗效:eDiabetes-Monitor SEEN糖尿病工作组研究
Diabetes Ther. 2015 Jun;6(2):173-85. doi: 10.1007/s13300-015-0112-4. Epub 2015 Jun 9.